There was no trend for cardiovascular death or all-cause mortality (79)
PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, MC4R, and FTO genes that influence your thermoregulation and metabolic sensitivity to GLP-1 compounds
Oral semaglutide represents a paradigm shift in preventive care
Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials
Always check with your doctor or pharmacist before starting any new medicine while using Maxiliv Injection
For patients who have tried GLP-1 medications before and stopped because of side effects, microdosing may be worth discussing with a provider
